Predicting and Communicating the Risk of Recurrence and Death in Women With Early-Stage Breast Cancer: A Systematic Review of Risk Prediction Models

The 70-Gene Signature as Prognostic Factor for Elderly Women with Hormone Receptor-Positive, HER2-Negative Breast Cancer

(2012) Steffi Hartmann et al.   Breast Care

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

(2012) G C Wishart et al.   BRITISH JOURNAL OF CANCER

Adjuvant therapy in stage I carcinoma of the breast

(2012) Gordon F. Schwartz et al.   CANCER

Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients

(2012) Nirmala Bhoo-Pathy et al.   EUROPEAN JOURNAL OF CANCER

Clinical Validity/Utility, Change in Practice Patterns, and Economic Implications of Risk Stratifiers to Predict Outcomes for Early-Stage Breast Cancer: A Systematic Review

(2012) J. Hornberger et al.   JNCI-Journal of the National Cancer Institute

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2011) S. Aebi et al.   ANNALS OF ONCOLOGY

Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool?

(2011) André Albergaria et al.   BMC CANCER

Improved web-based calculators for predicting breast carcinoma outcomes

(2011) James S. Michaelson et al.   BREAST CANCER RESEARCH AND TREATMENT

St. Gallen 2011: Summary of the Consensus Discussion

(2011) Michael Gnant et al.   Breast Care

A population-based validation of the prognostic model PREDICT for early breast cancer

(2011) G.C. Wishart et al.   EJSO

The 70-Gene Prognostic Signature for Korean Breast Cancer Patients

(2011) Kuk Young Na et al.   Journal of Breast Cancer

Anatomy and Biology: Two Complementary Sides of Breast Cancer Prognostication

(2011) Lajos Pusztai   JOURNAL OF CLINICAL ONCOLOGY

Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors

(2011) Gong Tang et al.   JOURNAL OF CLINICAL ONCOLOGY

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival

(2011) Ryan K. Van Laar   JOURNAL OF MOLECULAR DIAGNOSTICS

External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement

(2011) David Hajage et al.   PLoS One

Metastatic Potential of T1 Breast Cancer can be Predicted by the 70-gene MammaPrint Signature

(2010) Stella Mook et al.   ANNALS OF SURGICAL ONCOLOGY

Adjuvant!© Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer

(2010) Robert J. Paridaens et al.   BREAST CANCER RESEARCH AND TREATMENT

Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK

(2010) H E Campbell et al.   BRITISH JOURNAL OF CANCER

Accuracy of Perceived Risk of Recurrence Among Patients With Early-Stage Breast Cancer

(2010) Y. Liu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Adjuvant! Online as a Decision-making Tool in Early Breast Cancer — a UK National Survey

(2010) V. Agarwal et al.   CLINICAL ONCOLOGY

Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients with early stage breast cancer

(2010) Gevensleben   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

The Information Needs of New Radiotherapy Patients: How to Measure? Do They Want to Know Everything? And if Not, Why?

(2010) Maaike Zeguers et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Clinical Utility of the 70-gene MammaPrint Profile in a Japanese Population

(2010) M. Ishitobi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

(2010) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

Deconstructing the molecular portraits of breast cancer

(2010) Aleix Prat et al.   Molecular Oncology

A fuzzy gene expression-based computational approach improves breast cancer prognostication

(2010) Benjamin Haibe-Kains et al.   GENOME BIOLOGY

Additional value and potential use of the 70-gene prognosis signature in node-negative breast cancer in daily clinical practice

(2009) J. M. Bueno-de-Mesquita et al.   ANNALS OF ONCOLOGY

The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age

(2009) S. Mook et al.   ANNALS OF ONCOLOGY

An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom

(2009) H E Campbell et al.   BRITISH JOURNAL OF CANCER

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

(2009) Steven M Teutsch et al.   GENETICS IN MEDICINE

Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer

(2009) Kyoko Yorozuya et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study

(2009) Stella Mook et al.   LANCET ONCOLOGY

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

(2009) Kathy S Albain et al.   LANCET ONCOLOGY

Anchoring-and-Adjustment Bias in Communication of Disease Risk

(2009) Ibrahim Senay et al.   MEDICAL DECISION MAKING

Gene expression profiling: Decoding breast cancer

(2009) Femke de Snoo et al.   SURGICAL ONCOLOGY-OXFORD

Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial

(2008) M. Schmidt et al.   ANNALS OF ONCOLOGY

Patient Preferences for the Disclosure of Prognosis After Esophagectomy for Cancer with Curative Intent

(2008) Sjoerd M. Lagarde et al.   ANNALS OF SURGICAL ONCOLOGY

Merging microarray data from separate breast cancer studies provides a robust prognostic test

(2008) Lei Xu et al.   BMC BIOINFORMATICS

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

(2008) Stella Mook et al.   BREAST CANCER RESEARCH AND TREATMENT

Validation of 70-gene prognosis signature in node-negative breast cancer

(2008) J. M. Bueno-de-Mesquita et al.   BREAST CANCER RESEARCH AND TREATMENT

Improving understanding of adjuvant therapy options by using simpler risk graphics

(2008) Brian J. Zikmund-Fisher et al.   CANCER

Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort

(2008) B. S. Wittner et al.   CLINICAL CANCER RESEARCH

A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer

(2008) X.-J. Ma et al.   CLINICAL CANCER RESEARCH

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

(2008) Lori J. Goldstein et al.   JOURNAL OF CLINICAL ONCOLOGY